Abramson Cancer Center Support Grant

艾布拉姆森癌症中心支持补助金

• 批准号: 10425591
• 负责人: ROBERT H VONDERHEIDE
• 金额: $ 19.94万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10425591
• 关键词: Acquired Immunodeficiency Syndrome; Address; Adherence; Africa South of the Sahara; African; Aftercare; Botswana; Cancer Center Support Grant; Cancer Survivor; Caring; Cessation of life; Characteristics; Clinic; Clinical; Consolidated Framework for Implementation Research; Country; Data; Developing Countries; Diagnosis; Early Diagnosis; Early treatment; Ensure; Future; Geography; Goals; Grant; Gynecologic Oncology; HIV; HIV Infections; Hospitals; Incidence; Income; Intervention; Interview; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Methods; Morbidity - disease rate; Outcome; Patient-Focused Outcomes; Patients; Pattern; Persons; Prevalence; Private Hospitals; Quality of life; Radiation therapy; Recommendation; Research; Resources; Scientific Advances and Accomplishments; Shapes; Structure; Surveys; Testing; Woman; Work; advanced disease; anticancer research; care delivery; care outcomes; cohort; contextual factors; curative treatments; demographics; experience; falls; improved; infection rate; interest; low and middle-income countries; mortality; multidisciplinary; outreach clinics; psychosocial; response; screening; survivorship; transportation access; tumor; uptake

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 21-058. The number of cancer survivors living in low- and middle-income countries (LMICs) is expected to grow rapidly over the next decade driven in part by global advances in early detection and treatment, yet very little is known about the long-term needs of cancer survivors or delivery of survivorship care in LMICs. This supplement application will help to fill this critical research gap by quantitatively and qualitatively evaluating care outcomes and contextual determinants of survivorship care among women diagnosed with cervical cancer in Botswana. Cervical cancer is one of the leading cancers among women globally with 600,000 new cases and 340,000 deaths annually per 2020 estimates. Cervical cancer is an acquired immunodeficiency syndrome (AIDS)-defining malignancy, and countries with high rates of human immunodeficiency virus (HIV) have higher incidence of cervical cancer. Due to high HIV-infection rates and suboptimal screening uptake, most of the burden of cervical cancer incidence, morbidity, and mortality falls on LMICs particularly in sub-Saharan Africa, with many women presenting with advanced disease. Botswana, a sub-Saharan African country, has high rates of cervical cancer (incidence rate of 34.4 per 100,000) and HIV (18.5% prevalence), and a high rate of mortality due to cervical cancer (20.1 per 100,000) among women. To date, the majority of cancer research in Botswana and other LMICs has focused on early detection or treatment, with limited research evaluating the long-term physical or psychosocial outcomes in survivorship or how survivorship care may impact these outcomes. Furthermore, even less is known regarding which approaches may be most impactful and sustainable to deliver survivorship care in LMICs. As such, there is a critical need to understand the current state of survivorship in LMICs and to identify effective strategies to ensure that all women receive optimal survivorship care. The objectives of this project are to: 1) quantitatively describe a) patterns in post-treatment survivorship care and b) long-term physical and psychosocial sequelae of cervical cancer using an existing cohort of patients at Princess Marina Hospital in Gaborone, Botswana; and 2) qualitatively assess contextual determinants (e.g., quality of life, access to resources, care delivery strategies) shaping patient experiences and adherence to survivorship care. In combination, these data will be used to develop and/or adapt survivorship care interventions to target the specific contextual determinants in Botswana and other LMICs. The results of this project will advance scientific understanding of survivorship care and sequelae in LMICs and how these experiences may or may not differ from the experiences and needs of cancer survivors in high-income countries. This project will also generate fundamental evidence needed to improve survival and quality of life of cancer survivors globally. The long-term goal of this project is to decrease cervical cancer mortality in Botswana and other LMICs by developing and implementing survivorship care interventions that can be sustained in lower resource settings.

项目总结